EGFR and neoplasm: The expression of PD-L1 was induced by EGFR and JAK2/STAT1, while the inhibition of JAK2 repressed the upregulation of PD-L1 in tumor cells and enhanced their immunogenicity (Concha-Benavente et al., 2016).